-+ 0.00%
-+ 0.00%
-+ 0.00%

National Advertising Division Recommends Nucleus Genomics Modify or Discontinue Certain Claims for Nucleus IVF+ Embryo Screening; Nucleus to Appeal

Barchart·09/11/2026 09:00:00
Listen to the news

New York, NY, Sept. 11, 2026 (GLOBE NEWSWIRE) -- In a monitoring inquiry, BBB National Programs’ National Advertising Division recommended that Nucleus Genomics, Inc. modify or discontinue certain express and implied advertising claims for its Nucleus IVF+ service, including claims that Nucleus IVF+ could accurately compare embryos' disease risks, identify which embryo would grow up tallest or smartest, and determine a future child’s eye and hair colors. Nucleus will appeal the National Advertising Division’s (NAD) decision.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.